Cargando…
Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834484/ https://www.ncbi.nlm.nih.gov/pubmed/32562796 http://dx.doi.org/10.1016/j.jinf.2020.06.029 |
| _version_ | 1783642291204784128 |
|---|---|
| author | Liu, Furong Long, Xin Ji, Guibao Zhang, Bixiang Zhang, Wanguang Zhang, Zhanguo Chen, Xiaoping |
| author_facet | Liu, Furong Long, Xin Ji, Guibao Zhang, Bixiang Zhang, Wanguang Zhang, Zhanguo Chen, Xiaoping |
| author_sort | Liu, Furong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7834484 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78344842021-01-26 Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes Liu, Furong Long, Xin Ji, Guibao Zhang, Bixiang Zhang, Wanguang Zhang, Zhanguo Chen, Xiaoping J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2020-08 2020-06-17 /pmc/articles/PMC7834484/ /pubmed/32562796 http://dx.doi.org/10.1016/j.jinf.2020.06.029 Text en © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Liu, Furong Long, Xin Ji, Guibao Zhang, Bixiang Zhang, Wanguang Zhang, Zhanguo Chen, Xiaoping Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes |
| title | Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes |
| title_full | Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes |
| title_fullStr | Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes |
| title_full_unstemmed | Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes |
| title_short | Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes |
| title_sort | clinically significant portal hypertension in cirrhosis patients with covid-19: clinical characteristics and outcomes |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834484/ https://www.ncbi.nlm.nih.gov/pubmed/32562796 http://dx.doi.org/10.1016/j.jinf.2020.06.029 |
| work_keys_str_mv | AT liufurong clinicallysignificantportalhypertensionincirrhosispatientswithcovid19clinicalcharacteristicsandoutcomes AT longxin clinicallysignificantportalhypertensionincirrhosispatientswithcovid19clinicalcharacteristicsandoutcomes AT jiguibao clinicallysignificantportalhypertensionincirrhosispatientswithcovid19clinicalcharacteristicsandoutcomes AT zhangbixiang clinicallysignificantportalhypertensionincirrhosispatientswithcovid19clinicalcharacteristicsandoutcomes AT zhangwanguang clinicallysignificantportalhypertensionincirrhosispatientswithcovid19clinicalcharacteristicsandoutcomes AT zhangzhanguo clinicallysignificantportalhypertensionincirrhosispatientswithcovid19clinicalcharacteristicsandoutcomes AT chenxiaoping clinicallysignificantportalhypertensionincirrhosispatientswithcovid19clinicalcharacteristicsandoutcomes |